Ceftriaxone: Therapeutic Uses and Mechanism of Action

Q: Ceftriaxone and Therapeutic Uses

Ceftriaxone is a third-generation cephalosporin antibiotic that is widely used in clinical settings due to its broad-spectrum antibacterial activity and convenient once-daily dosing. It is administered parenterally (usually IV or IM) and is especially useful for treating moderate to severe infections.

Mechanism of Action

Ceftriaxone works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), interfering with the final step of peptidoglycan synthesis, leading to bacterial cell lysis and death.

Therapeutic Uses of Ceftriaxone

Central Nervous System Infections

Bacterial meningitis (especially in children and adults):

• Covers Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, etc.

Respiratory Tract Infections

• Community-acquired pneumonia (CAP)
• Hospital-acquired pneumonia (as part of combination therapy)
• Covers S. pneumoniae, H. influenzae, and some Gram-negative bacilli

Septicemia and Bacteremia

Effective for bloodstream infections caused by susceptible organisms.

Urinary Tract Infections (UTIs)

• Especially complicated UTIs and pyelonephritis
• Active against Escherichia coli, Klebsiella, Proteus, etc.

Gonorrhea and Pelvic Inflammatory Disease

• Gonorrhea: First-line treatment for Neisseria gonorrhoeae (single-dose IM injection).
• Pelvic Inflammatory Disease (PID): Used in combination with other antibiotics like doxycycline and metronidazole.

Bone, Joint, and Heart Infections

• Bone and Joint Infections: Osteomyelitis and septic arthritis.
• Endocarditis: Particularly for Streptococcus viridans, Enterococcus, or HACEK organisms.

Surgical Prophylaxis and Neonatal Care

• Surgical Prophylaxis: For certain high-risk procedures (e.g., GI or genitourinary surgery).
• Neonatal Infections: Neonatal sepsis and meningitis (except in preterm infants with hyperbilirubinemia due to risk of kernicterus).

Important Warnings and Contraindications

• Not effective against Pseudomonas aeruginosa (use cefepime or ceftazidime instead).
• Avoid in neonates with hyperbilirubinemia (risk of bilirubin displacement).
• Calcium interaction: Risk of precipitation if mixed with calcium-containing IV fluids.

Common Dosing and Administration

• Typical dose: 1–2 g IV/IM once daily, up to 4 g/day in severe infections.
• For gonorrhea: 250–500 mg IM single dose.

Let me know if you want a chart, mnemonics, or clinical case examples to go along with this.